HIF1A and neoplasm: In addition, some authors, with a proteomic approach, support the possibility that this dipeptide affects tumour cell growth in the human glioma cells and retards tumour growth in vivo in a NIH3T3-HER2/neu mouse model through an interference with protein folding/processing and HIF-1α signalling [3]–[4].